Title of article
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial
Author/Authors
Otto R Hommes، نويسنده , , Per S Sorensen، نويسنده , , Franz Fazekas، نويسنده , , Monika Maas Enriquez، نويسنده , , Hans W Koelmel، نويسنده , , Oscar Fernandez، نويسنده , , Carlo Pozzilli، نويسنده , , Paul OʹConnor، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
8
From page
1149
To page
1156
Abstract
Background
Several double-blind placebo-controlled trials of relapsing-remitting multiple sclerosis have shown beneficial effects of intravenous immunoglobulin (IVIG) on relapse rate and disability. The European Study on Intravenous Immunoglobulin in Mult
Journal title
The Lancet
Serial Year
2004
Journal title
The Lancet
Record number
587058
Link To Document